He expressed no symptoms supporting GCA and inflammation biomarkers were within normal limits
1 Specifically, 77.3% of those in the semaglutide group saw improved function scores compared to just 42.9% in the placebo group
The phase 2b ENLIVEN trial, a multicenter, randomized, double-blind, placebo-controlled study, included 222 patients with biopsy-confirmed NASH and F2-F3 fibrosis, assigned to receive pegozafermin at doses of 15 mg weekly, 30 mg weekly, 44 mg every 2 weeks, or placebo for 24 weeks
Supplying your body with glutathione before bed may support these nocturnal repair cycles
All three compounds in the GLP-1 drug class, including Retatrutide, Tirzepatide, and Semaglutide, activate this receptor